Clinical Trials Search Results 1 2 3 4 5 6 1 - 10 of 60 Results Pancreatic Cancer Neoadjuvant - Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer Combination Chemotherapy With or Without CyberKnife Before Surgery in Treating Patients With Pancreatic Cancer Read More Acute Lymphoblastic Leukemia - Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia Studies how well blinatumomab works compared with standard combination chemotherapy. Read More AML - Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD) Read More EGFR Positive NSCLC - AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy To assess the efficacy and safety of AZD9291 versus Placebo. Read More Neuropsychological and Behavioral Testing in Younger Patients With Cancer Studies neuropsychological and behavioral testing in younger patients. Read More All types NSCLC - Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (ANVIL) Studies how well nivolumab after surgery and chemotherapy work in treating patients with stage IB-IIIA non-small cell lung cancer. Read More All types NSCLC - An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers Read More Soft-Tissue Sarcoma - Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Studies how well pazopanib hydrochloride, combination chemotherapy, and radiation therapy work. Read More HER2 Positive BC - Study of Tucatinib vs Placebo With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer The purpose of this study is to assess the effect of tucatinib vs. placebo in combination with capecitabine and trastuzumab on progression-free survival (PFS) per RECIST 1.1 based on independent central review. Learn more at Clinicaltrials.gov NCT02614794 Read More Germ Cell Tumors - Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Read More 1 2 3 4 5 6 1 - 10 of 60 Results